WHO data suggests richer countries have so far received 87 per cent of doses globally.
Waiving patents on COVID-19 vaccines would remove “a legal hurdle” to companies and developing countries producing the shots and fixing a global supply problem, says an advocate with Oxfam Canada.
“It allows them to produce it without having to worry about being taken to court or having other kinds of financial or punitive measures lobbied at them for infringing patents,” said Siham Rayale, Oxfam Canada’s policy and advocacy lead on humanitarian and refugee issues.
Oxfam is among organizations supporting India and South Africa’s call for the World Trade Organization (WTO) to temporarily suspend patents and intellectual property (IP) rules on vaccines, for the course of the pandemic.
Data from the World Health Organization, released earlier this month, suggests richer countries have so far received 87 per cent of COVID-19 vaccines, with low-income countries receiving just 0.2 per cent. That waiver would allow countries to “rapidly scale up vaccine manufacturing and production,” Rayale told The Current’s Matt Galloway.
The call to suspend the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement is backed by dozens of developing countries, but has not received support from some G7 countries since it was initially proposed last October.
With another meeting about the issue scheduled for this week, a group of 170 former heads of state and Nobel laureates wrote to U.S. President Joe Biden this month, urging him to waive U.S. intellectual property rules and support the proposal at the WTO. The White house said Tuesday that a decision has not been reached.
In Canada, the federal government insists it “has not rejected the waiver proposal,” but still has questions, and is committed to finding “consensus-based solutions.”
Speaking to The Current in February, Microsoft co-founder Bill Gates said he didn’t believe an IP waiver would solve the supply problem.
“It’s about these factories being exactly right and passing strict regulatory review,” said Gates, who has donated $1.75 billion to the fight against COVID-19.
“There are very few high quality vaccine factories in the world. And IP is not the issue.”
Rayale disagreed, saying “you don’t have to go far to look for manufacturing capacity to be able to produce vaccines, particularly in the global south.”
She said there are facilities in Morocco, Algeria, Tunisia, Senegal and Egypt that are already producing other vaccines and could pivot to COVID-19 shot production.
South Africa has already provided details of these and other options to the WTO, she said.
“All it takes is investment in existing infrastructure that can be repurposed to make COVID-19 vaccines,” she said.
She also dismissed the argument that removing IP protection would discourage companies from investing in vaccines, reiterating that the waiver is temporary.
Several companies also received billions in public money to develop COVID-19 vaccines, she added, but much of the profits will go to company shareholders, not back to the public purse.
Removing protection will hamper collaboration: expert
Andrei Iancu, the former director of the U.S. Patent and Trademark Office, argued that removing patent protection “would slow down vaccine distribution.”
Patents have allowed companies to enter into international collaborations in developing and producing vaccines, said Iancu, a partner at the law firm Irell & Manella, in California.
“Major competitors are collaborating: Johnson & Johnson and Merck, Pfizer and Novartis,” he told Galloway.
“Without IP, these companies would be much more reluctant to enter into these collaboration agreements.”
Under TRIPS, signatory countries can issue compulsory licences that allow someone else to produce patented products, if it’s deemed necessary to the public interest, Iancu said.
He argued countries aren’t issuing those licences because the vaccines aren’t easy to produce without the input of the original manufacturer.
He also warned that without protection, companies “retreat into their trade-secrets shells,” which slows progress via a lack of collaboration.
Iancu noted that roughly 10 billion doses of COVID-19 vaccines are expected to be produced by the end of the year.
“Before disrupting this incredibly complex intellectual property system … we need to be really sure that we know exactly what we’re doing here and we have the evidence that A, it’s necessary and B, it actually will solve the problems,” he said.
Export restrictions slowing distribution
Removing patents and IP protections won’t solve the vaccine supply problem on its own, said Gian Gandhi of UNICEF, who acts as coordinator for COVAX, the global initiative aimed at ensuring equitable distribution of COVID-19 vaccines
“It’s not really a patent issue that’s stopping the scale of production, but actually forms of vaccine nationalism either to keep vaccines within borders, or to keep the components necessary for producing them within borders,” he told Galloway.
The E.U., the U.S. and India have all imposed export restrictions on vaccines, as they try to manage low supply and rising outbreaks on their own territory.
Until every country in the world has a high vaccination rate, the virus has the opportunity “to both replicate and frankly mutate,” Gandhi said.
“Even a fully vaccinated population in a high-income country may be at risk from variants that evade the current vaccines,” he said.
“Increasing the levels of coverage in developing countries makes sense both abroad, but certainly at home for the wealthier countries.”
News
Common Medication Could Save Half a Million Lives Each Year – So Why Isn’t It?
A recent study conducted by scientists at the University of Southern California sheds light on the reasons why children are not receiving an affordable and effective diarrhea treatment. Medical professionals in developing nations are [...]
X Marks the Spot: AI’s Treasure Maps Lead to Early Disease Detection
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors [...]
Scientists Discover Method To Identify Alzheimer’s Disease Before It Progresses to Dementia
Researchers at Aarhus University have discovered a method to identify Alzheimer’s disease before it progresses to dementia, potentially opening up new avenues for treatment. A groundbreaking study could pave the way for early detection [...]
Startling Discovery: COVID-19 Virus Can Stay in the Body More Than a Year After Infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential [...]
New bioengineered protein design shows promise in fighting COVID-19
In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat [...]
Sugar-coated gold nanoparticles can quickly eliminate bacterial infections, no antibiotics required
If left to their own devices, bacteria on our teeth or wounded skin can encase themselves in a slimy scaffolding, turning into what is called biofilm. These bacteria wreak havoc on our tissue and, [...]
Liquid Lightning: Nanotechnology Unlocks New Energy
EPFL researchers have discovered that nanoscale devices harnessing the hydroelectric effect can harvest electricity from the evaporation of fluids with higher ion concentrations than purified water, revealing a vast untapped energy potential. Evaporation is a natural [...]
Unmasking the Illusion: AI-Generated Faces Challenge Perceptions
Research shows survey participants duped by AI-generated images nearly 40 percent of the time. If you recently had trouble figuring out if an image of a person is real or generated through artificial intelligence [...]
New Discovery Reveals How Cells Defend Themselves During Stressful Situations
Stress granules play a crucial role in the stress response, arising from the aggregation of non-translating mRNAs and proteins. Although significant knowledge exists about stress granules, the mechanisms behind their mRNA localization remain partially [...]
Scientists use a new type of nanoparticle that can both deliver vaccines and act as an adjuvant
Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system's response [...]
Not Science Fiction: How Optical Neural Networks Are Revolutionizing AI
A novel architecture for optical neural networks utilizes wavefront shaping to precisely manipulate the travel of ultrashort pulses through multimode fibers, enabling nonlinear optical computation. Present-day artificial intelligence systems rely on billions of adjustable [...]
Turning skin cells into limb cells sets the stage for regenerative therapy
In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts — the most commonly found cells in skin and connective tissue — into [...]
AI reveals prostate cancer is not just one disease
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer, which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study, published in Cell Genomics, has revealed [...]
New Study Finds That Persistent COVID-19 Infections Are Surprisingly Common
Recent research conducted by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the journal Nature. [...]
Innovative nanosheet method revolutionizes brain imaging for multi-scale and long-term studies
The human brain has billions of neurons. Working together, they enable higher-order brain functions such as cognition and complex behaviors. To study these higher-order brain functions, it is important to understand how neural activity [...]
Scientists Have Discovered a Potential Universal Antivenom
Scientists at Scripps Research identified antibodies that protect against a host of lethal snake venoms. Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of [...]